‘It’s Pure Bliss’: Pharmaceutical pleasures in later-life use of sleeping medication

• Shows pleasure sustains long-term use of prescribed hypnotics in later life. • Identifies end-oriented and non-end-oriented pharmaceutical pleasures. • Introduces the concept of quiet, domesticated pleasures. • Combines episodic interviews with solicited medication diaries. • Guides international deprescribing by addressing affective attachments. While research on prescribed sleeping medications has largely focused on risks and regulation, this paper examines a less explored dimension: the pleasures of long-term use. Drawing on qualitative interviews and diaries with 38 UK users aged 65+, it examines not only pharmacological effects but also the emotional, sensory, and symbolic dimensions of use, showing how pharmaceutical effects are enacted through embodied routines, expectations and everyday practices. Rather than incidental to therapeutic intent, pleasure is shown to be central to the enduring appeal and embeddedness of sleeping medication use among older adults. Drawing on social constructivist and phenomenological perspectives, the analysis foregrounds participants’ descriptions of comfort, stillness, warmth, and control, showing how these sensations are sustained through nightly routines and rhythms, forming what we term quiet, domesticated pharmaceutical pleasures. The paper makes three key contributions: first, it positions pleasure as a central sustaining dimension of the long-term use of sleeping medication; second, it distinguishes between end-oriented pleasures (the achievement of sleep) and non-end-oriented pleasures- experienced during bedtime and the lead-up to sleep- which are embedded in ritual and anticipation; and third, it advances a sociological account that reconceptualizes pleasure as relational, embodied, and symbolically mediated, rather than reducible to pharmacological effects. In doing so, the paper advances a broader understanding of pharmaceutical life and how pleasure operates within licit, long-term, and emotionally meaningful drug use.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Policy
Published
2026-03-28
DOI
https://doi.org/10.1016/j.drugpo.2026.105248
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

‘It’s Pure Bliss’: Pharmaceutical pleasures in later-life use of sleeping medication

Hannah Farrimond, Georgia Smith
International Journal of Drug Policy
Sleep and related disorders
article

‘It’s Pure Bliss’: Pharmaceutical pleasures in later-life use of sleeping medication

Hannah Farrimond, Georgia Smith
article en

Abstract

• Shows pleasure sustains long-term use of prescribed hypnotics in later life. • Identifies end-oriented and non-end-oriented pharmaceutical pleasures. • Introduces the concept of quiet, domesticated pleasures. • Combines episodic interviews with solicited medication diaries. • Guides international deprescribing by addressing affective attachments. While research on prescribed sleeping medications has largely focused on risks and regulation, this paper examines a less explored dimension: the pleasures of long-term use. Drawing on qualitative interviews and diaries with 38 UK users aged 65+, it examines not only pharmacological effects but also the emotional, sensory, and symbolic dimensions of use, showing how pharmaceutical effects are enacted through embodied routines, expectations and everyday practices. Rather than incidental to therapeutic intent, pleasure is shown to be central to the enduring appeal and embeddedness of sleeping medication use among older adults. Drawing on social constructivist and phenomenological perspectives, the analysis foregrounds participants’ descriptions of comfort, stillness, warmth, and control, showing how these sensations are sustained through nightly routines and rhythms, forming what we term quiet, domesticated pharmaceutical pleasures. The paper makes three key contributions: first, it positions pleasure as a central sustaining dimension of the long-term use of sleeping medication; second, it distinguishes between end-oriented pleasures (the achievement of sleep) and non-end-oriented pleasures- experienced during bedtime and the lead-up to sleep- which are embedded in ritual and anticipation; and third, it advances a sociological account that reconceptualizes pleasure as relational, embodied, and symbolically mediated, rather than reducible to pharmacological effects. In doing so, the paper advances a broader understanding of pharmaceutical life and how pleasure operates within licit, long-term, and emotionally meaningful drug use.

International Journal of Drug PolicyVol. 152
University of Exeter (GB)
Openalex Percentile: Top 4%
Sleep and related disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

‘It’s Pure Bliss’: Pharmaceutical pleasures in later-life use of sleeping medication — Hannah Farrimond, Georgia Smith · International Journal of Drug Policy (2026) | TGRS Research Map | TGRS